Atlas Trials

Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del

Clinical trial NCT02653027 · WITHDRAWN

Trial details

NCT number
NCT02653027
Sponsor
Massachusetts General Hospital
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
DiabetesCystic Fibrosis
Start date
2018-01-01
Primary completion
2018-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.